• SENSEX 72,529.07
    -242.65 (--0.33%)
  • BANKNIFTY 54,259.95
    -211.70 (--0.39%)
  • Cube Highways
    156.41 162.00(%)
  • NSE
    1,793.70 1,878.00(%)
  • 360 ONE
    1,019.75 906.20(%)
  • SS Retail
    775.00 888.00(%)
  • Cupid
    292.35 298.95(%)
  • R Systems Intl.
    305.25 446.55(%)
  • GE Vernova T&D
    4,225.00 5,650.00(%)
  • Lords Mark Industries
    84.89 60.00(%)
  • PB Fintech.
    1,076.35 1,076.35(%)
  • Azad Engineering
    2,997.65 2,997.65(%)
  • Hero Motors
    140.75 156.03(%)
  • HDFC Bank
    720.00 1,020.35(%)
  • Reliance Industries
    1,182.05 1,182.05(%)
  • Delhivery
    418.15 524.25(%)
  • Ather Energy
    1,404.00 542.20(%)
  • Varmora Granito
    163.45 163.45(%)
  • Bharti Airtel
    1,788.00 2,174.70(%)
  • Indian Hotels Co
    725.50 757.10(%)
  • ICICI Lombard
    1,498.00 1,423.95(%)
  • Bajaj Finance
    961.65 788.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Accretion Nutraveda Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 96003.0
  • ISIN : INE1KVQ01019
292.00 22 (8.23%)
  • As on 29 Sep 2026 (EOD)

  • Today’s Low

    292.00

  • Today’s High

    292.00

  • Open

    292.00

  • Perv Close

    269.80

  • 52W Low

    150.10

  • 52W High

    313.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    211.41

  • Div & Yield %

    0.00

  • Book Value(₹)

    49.00

  • Debt-Equity Ratio

    8.23

  • AGM Date

    29-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    211.41

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.24

  • BV (₹)

    49.00

  • Sales( ₹ in Cr.)

    33.60

  • NP (in Cr.)

    5.07

  • NP Var(%)

    103.0

  • Div%

    0.0

  • CPS (₹)

    7.40

  • EPS (₹)

    7.00

  • Traded Value (₹ in Lakhs)

    211.41

  • 52 Week High

    313.00

  • 52 Week Low

    150.10

  • Price BSE

    292.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    211.41

  • P/C Ratio

    39.70

  • P/E Ratio

    41.70

  • Price Vs.BV

    7.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar
INCOME :            
Sales Turnover 33.60 16.00 5.01 2.90 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 33.60 16.00 5.01 2.90 - -
Other Income 0.11 0.01 0.19 0.17 - -
Stock Adjustments 0.96 0.95 1.30 0.00 - -
Total Income 34.67 16.96 6.50 3.07 - -
EXPENDITURE :            
Raw Materials 25.07 11.52 4.16 1.70 - -
Power and Fuel Cost 0.14 0.11 0.09 0.04 - -
Employee Cost 0.50 0.23 0.18 0.10 - -
Other Manufacturing Expenses 0.81 0.64 0.32 0.17 - -
Selling and Administration Expenses 1.10 0.71 0.32 0.27 - -
Miscellaneous Expenses 0.05 0.02 0.01 0.00 - -
Employee Benefit Expenses 0.50 0.23 0.18 0.10 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 27.68 13.23 5.08 2.28 - -
Operating Profit 7.00 3.72 1.42 0.79 - -
Interest 0.53 0.35 0.24 0.19 - -
Gross Profit 6.47 3.37 1.18 0.60 - -
Depreciation 0.26 0.22 0.26 0.31 - -
Profit Before Tax 6.21 3.15 0.92 0.29 - -
Current Tax 1.14 0.65 0.10 0.00 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax 0.00 0.00 -0.01 0.01 - -
Reported Net Profit 5.07 2.50 0.82 0.28 - -
Extraordinary Items 0.00 0.00 0.00 0.00 - -
Adjusted Net Profit 5.07 2.50 0.82 0.28 - -
Adjustment below Net Profit -2.72 0.00 0.00 0.00 - -
P & L Balance brought forward 3.04 0.54 -0.10 -0.38 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 5.39 3.04 0.72 -0.10 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 7.00 51.35 22.83 7.79 - -
Earnings Per Share(Adj)-Unit Curr 7.00 - - - - -
Book Value 49.00 103.74 30.14 7.31 - -
Book Value(Adj)-Unit Curr 49.00 - - - - -

Shareholding Pattern

  • Promoter Group

    73.48%

  • Public Share Holding

    26.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,320,000 73.48 5,320,000 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,320,000 73.48 5,320,000 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 78,000 1.08 78,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 442,000 6.11 442,000 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 520,000 7.18 520,000 4
2] Non Institution
Bodies Corporate 147,000 2.03 147,000 9
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5,000 0.07 5,000 2
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 106,000 1.46 106,000 43
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 317,000 4.38 317,000 7
Individuals holding nominal share capital up to Rs. 1 lakh 825,000 11.40 825,000 321
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,400,000 19.34 1,400,000 382
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,240,000 100.00 7,240,000 396

Company Background

Accretion Nutraveda LtdPharmaceuticals - Indian - Formulations

  • Accretion Nutraveda Ltd
  • BSE Code : 96003.0
  • ISIN : INE1KVQ01019

  • Incorporation Year

    2021

  • Registered Office

    27 Xcelon Industrial Park-1
    Vasna-Chacharwadi Ta Sanand, Ahmedabad,
    Gujarat-382213

  • Telephone

    +91 99043 66177

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Payal Hareshbhai Kotadiya

  • Auditor

    VSSB & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Accretion Nutraveda Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Accretion Nutraveda 292.00 33.72 33.60 0.00 27.73
Abbott India 27,266.65 7,217.19 6,929.05 35.88 43.78
Astrazeneca Phar 6,254.35 2,304.07 2,275.58 92.18 27.86
Glaxosmi. Pharma 2,787.25 3,932.76 3,790.20 44.52 58.17
Novartis India 1,933.35 393.10 354.33 48.82 15.94
Cipla 1,383.00 20,102.60 18,979.95 36.35 13.88
Bliss GVS Pharma 710.05 773.53 729.81 65.99 12.51
Fermenta Biotec. 549.30 474.15 450.25 25.64 18.77
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Guj. Themis Bio. 404.40 168.25 165.82 108.13 18.05
Ambalal Sarabhai 39.24 19.52 3.94 72.67 6.77